Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children

Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children

Background: Ceftazidime-Avibactam (CAZ-AVI) plays a key role in the treatment of Multidrug Resistant Gram-Negative Bacilli (MDR-GNB) infections. In pediatrics, CAZ-AVI is clinically approved for treatment of urinary tract or intra-abdominal infection. However, there is limited data available about i...

Full description

Saved in:
Bibliographic Details
Main Authors: Wilson Toyohiro Hoshino, Adriana Maria Paixão De Sousa da Silva, Antonio Carlos Pignatari, Ana Cristina Gales, Fabianne Carlesse
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Children
Pediatric
Ceftazidime-avibactam
Febrile neutropenia
Cancer
Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867025000182
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items